Member Info for bobbust

I think his point was there are a lot of test bed fusion reactor's Pland

To get a raised offer of 40p.

They have bought more so I doubt they are going anywhere

This RNS points out more possible uses for Angle. This increases the potential revenue down the line.

It is highlighting that when this is accepted it will have a large number of uses and thus a large revenue.

It also points out this is the best way to harvest CTC's.

With a MC of £4m, loads of potential, deals done and deals to come this could go up very quickly.

Cash is tight but they sould have enough.

Practive investors talk positive.

but untill more deals are signed this can and will go up, down or stay the same depending on volume.

A rise is not pump and dump or a leak or a cash raise.

Today more bought, only £122,000 bought today according to LSE.

Just because its fallen does not mean it can't go up

Thanks Burble.

Very intresting the increase in potency.

Yes poor understanding of what this means.

We have two products in trials and one of them has just had approval to double the number of patients who could benefit.!!!!!

Great news to move forward with SCIB1+.

Will double the size of the market.

Unbelievable that this is at £100m MC.

I wonder if we will get a further update at the half year . Probably next week.

20% capture rate, not very good.

whats Angle 90%?

in thursdays the 4th RNS they captured on every sample

You should look at the link you posted.

Scroll down to paragraph 5 and click the highlighted link "minimally invasive cell-based blood cancer test"

Its about ANGLE

It is a very long process to harvest CTC's.

Its old technology.

One technician can run 20 Angle machines at once.

Given the size of the market it wont be a problem

Https://www.cnbc.com/2024/01/10/saudi-arabia-nearly-doubles-estimate-for-the-value-of-its-mineral-resources-.html

Looks like it could be right time right place

Very interesting.

They are almost there.

Will be adding a few tomorrow

Very good presentation tonight.

All about commercialisation.

Lots of fingers in lots of pies.

They are not planning a fund raise.

They will try to get to cash positive with the cash they have.

Stated that.

Revenue is increasing

He clearly states that they are going out to Dr's to get this used in treatments.

This could be a standard test for all reciving treatment in a few years

Should be intresting to ask about route to commercialisation.

Also have a few fusion antibodies

Thought this would be creeping up with the uranium price.

Interesting article there.

US bank coverage again with 30p target.

https://www.proactiveinvestors.co.uk/companies/news/1037493/scancell-us-investment-bank-resumes-coverage-with-punchy-price-target-1037493.html

This is not a treatment it's a diagnostic tool.

It improves doctors knowledge of what they are dealing with.

It will help 60% get the correct treatment 1st time round. Not a guess as it would be

Due to the huge numbers of trades and how robust the SP is I am surprised at people talking a profit.

Definitely looking more likely to go up than down at present.

Sorry if this causes a drop!!!!

18m so far and it's 9.30.

Yesterday 41m

It's only profit taking that is slowing the rise down